An antiviral solution to deactivate wheat dwarf virus

The antiviral solution using RNP structures with graphene oxide and CRISPR-Cas12a targets the wheat dwarf virus's capsid protein, directly inactivating it on plant surfaces without genetic modification, addressing the limitations of existing methods by ensuring safety, cost-effectiveness, and preventing virus replication.

WO2024248759A1PCT designated stage expired Publication Date: 2024-12-05T C USKUDAR UNIVERSITESI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/TR2023/051843
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-12-29
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

Current methods for combating wheat dwarf virus, such as pesticides and genetic modification using CRISPR-Cas9, pose health risks and economic losses, are costly, and have low effectiveness due to genetic changes and toxicity, while existing solutions fail to directly inactivate the virus without altering plant genetics.

Method used

An antiviral solution containing ribonucleic protein (RNP) structures packaged with graphene oxide, created from Cas12a and guide RNAs, targets the capsid protein of the wheat dwarf virus using the CRISPR system, applied in spray form to directly inactivate the virus without genetic modification, utilizing guide RNAs specific to the virus's DNA sequences to cause DNA breaks and inhibit replication.

Benefits of technology

The solution effectively neutralizes the wheat dwarf virus on plant surfaces, preventing replication and spread without altering plant genetics, is cost-effective, and safe for consumption, providing a stable and targeted approach to virus inhibition.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 000014
    Figure 000014
  • Figure 00000013_0000
    Figure 00000013_0000
Patent Text Reader

Abstract

The invention relates to an antiviral solution that is packaged with graphene oxide that enables the direct inactivation of the wheat dwarf virus, which causes yellowing and dwarfism in wheat and / or barley, on the plant surface, and comprises the ribonucleic protein (RNP) structure created from Cas12 and guide RNAs through the CRISPR system and the preparation method of this solution. The guide RNAs used in the invention target the capsid proteins (CP) coding region of the wheat dwarf virus and inhibit the virus by causing DNA breaks in the relevant region with the Cas12(a) enzyme. The application of said antiviral solution to the infected plant is by spraying it in spray form. By applying the RNPs contained in the antiviral solution of the invention in spray form to the leaves of the plant, no modification occurs in the genetics of the applied plant, the genome of the wheat dwarf virus is directly targeted.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] AN ANTIVIRAL SOLUTION TO DEACTIVATE WHEAT DWARF VIRUS

[0002] Technical Field

[0003] The invention relates to an antiviral solution that is packaged with graphene oxide that enables the direct inactivation of the wheat dwarf virus, which causes yellowing and dwarfism in wheat and / or barley, on the plant surface, and comprises the ribonucleic protein (RNP) structure created from Cas12a and guide RNAs through the CRISPR system and the preparation method of this solution. Said antiviral solution is applied to the plant in spray form. By applying the RNPs contained in the antiviral solution of the invention to the leaves of the plant in spray form, no modification occurs in the genetics of the applied plant.

[0004] State of the Art

[0005] Wheat, which forms the raw material of bread, is a very important grain product. Wheat, which can grow in many regions of Turkey, is important for human nutrition with its nutritional content and is used as a food source in animal production and in various industrial areas. Abiotic and biotic stress factors in grain production reduce grain yield and negatively affect product quality. Virus-related diseases, which are biotic stress factors that cause a decrease in yield and quality, greatly limit grain production worldwide, and the most important viral disease factor limiting grain production is wheat dwarf virus (WDV), which is an exceptional family of plant viruses with a DNA genome in the Geminiviridae family. The virus is generally transmitted to the plant by the leafhopper Psammotettix alienus (wandering cicada) biting the plant, and the vector (cicada) carries the infection throughout its life. Therefore, due to the high mobility of cicadas, infections can spread rapidly in a crop [1]. Apart from vector insects, wild type grasses that grow unnoticed in the field are another source of transmission of the virus to the next production season, and the vectors that feed on these grasses spread the virus to the field very quickly. Due to WDV infection, which occurs as a result of the transfer of the virus to plants, streaking on wheat and barley leaves, chlorosis, decrease in the number of spikes, decrease in winter hardiness, weakening or complete inhibition of root development and death of plants in the early development stage occur [2], Additionally, depending on the time of infection (especially in the case of infection occurring in the early development period), yield losses of up to 100% may occur.

[0006] Geminiviridae is a family of plant viruses that encode their genetic information on a circular genome of single-stranded DNA. There are 520 species divided into 14 genera in this family. One of these genera, Mastrevirus, which causes wheat dwarf virus, has a monopartite single-stranded circular DNA genome, and the typical Mastrevirus genome encodes four different proteins: movement protein (MP), capsid protein (CP), and two replication-associated proteins (Rep and RepA). The presence of an intron in the Rep gene enables mastreviruses to produce two different forms of the replication protein. The long intergenic region (LIR) and short intergenic region (SIR) contain sequence elements required for viral replication and transcription, and replication-associated RepA is a specific protein of this species as well as a generally conserved region. CP protein mediates vector (Psammotettix alienus) transmission and is vector specific. In addition, the genetic material of the virus is stored in this protein structure. The capsid is a "shield" that prevents viral nucleic acids from being degraded by host enzymes, chemicals, or the activity of other pests. It also enables the virion to attach to the host (wheat or barley) and penetrate the host cell membrane.

[0007] In the state of the art, pesticides are widely used to combat wheat dwarf virus. Pesticides, which are commonly used in spray form today, adhere to the surfaces of vegetables and fruits as a result of adsorption. In addition, it leaves residue not only on fruits and vegetables but also in the soil, resulting in a decrease in soil fertility. If sufficient purification is not achieved in these foods, which are sometimes consumed raw, they can pass into the system of the creatures that consume them through the digestive system or enter the bloodstream by accidental inhalation or absorption through the skin as a result of contact, and by reaching vital organs and systems, it causes acute poisoning and allergic reactions in the short term, or genetic damage in the long term, especially in people who are chronically exposed, and thus causes cancer [3]. In addition, disruptions in the liver, kidneys and muscle systems may also occur. Another method frequently used in the combat against wheat dwarf virus in the state of the art is to plant as late as possible in the land where the virus is present. When the planting of wheat or barley is postponed beyond normal time, disease transmission from vectors with primary infection is prevented. However, as stated, in this practice, the planting time is shifted, thus the harvest of the product is delayed, and economic losses occur accordingly.

[0008] In the state-of-the-art patent application numbered WO2016185411 A1 , methods of inhibiting viral infections of a plant by delivering a viral-specific sgRNA to a plant cell expressing Cas9 endonuclease are described. In said invention, the CRISPR system includes a guide RNA and Cas9 enzyme. It is also mentioned that when sgRNA and Cas9 are expressed in a cell, the genomic target sequence may be altered or permanently disrupted. Although it is said that the virus inhibited in the invention may be from the Geminiviridae family, there is no explanation about directly inhibiting the wheat dwarf virus. In addition, in said document, the plant was genetically modified directly with CRISPR-Cas9, but in the present invention, only the wheat dwarf virus is inhibited without making any changes in the genetics of the plant. In the mentioned document, since the inhibition of viral infections is achieved by genetically changing the plant, this practice is both difficult and costly.

[0009] In a study in the state of the art conducted by Zhang et al., developments in ribonucleic protein (RNP)-mediated genetic engineering of plants are described [4], Particle bombardment is said to be another widely used approach to deliver RNPs to plant tissues and cells. It is noted that explants typically used for plant regeneration, including embryos and leaf discs, can be used as targets of RNP-coated particles. It is also described that RNP-mediated genome editing using particle bombardment has been successfully demonstrated in wheat. The ribonucleic protein structure described in said document is transferred to the plant's genome, that is, there is a genetic change. In addition, although said genome editing was done on the wheat plant, there is no information on inhibiting or inactivating the wheat dwarf virus in any way.

[0010] In a study in the state of the art conducted by Doyle et al., genome editing of GFP, Cas9, gRNA and SPO11 genes added to wheat by spraying plasmid-coated carbon dots onto the leaves is described [5]. It is stated that said procedure is a spray gene editing protocol. Said document comprises the application of the CRISPR system in spray form, but here the wheat is genetically modified by genome editing.

[0011] Due to reasons such as the limitations and inadequacies of the solutions in the state of the art, the methods used against the wheat dwarf virus in the state of the art posing a danger to the health of living beings and cause economic losses, applications in the state of the art in spray form in which the CRISPR system is integrated changing the genetics of the plant, therefore the applications being costly and their effectiveness being low because the RNP structures in the system are not sufficiently stable, and the chemicals (pesticides) used having toxic effects on the plant, it was necessary to develop an application that neutralizes the wheat dwarf virus.

[0012] Brief Description and Aims of the Invention

[0013] The invention describes an antiviral solution containing the ribonucleic protein (RNP) structure that is packaged with graphene oxide, directly neutralises the wheat dwarf virus, which causes yellowing and dwarfism in wheat and / or barley, on the plant surface, and created from Cas12(a) and guide RNAs (Guide RNA-1 with the nucleotide sequence of SEQ ID NO:1 , Guide RNA-2 with the nucleotide sequence of SEQ ID NO:2, Guide RNA- 3 with the nucleotide sequence of SEQ ID NO:3, Guide RNA-4 with the nucleotide sequence of SEQ ID NO:4 and guide RNA-5 with the nucleotide sequence of SEQ ID NO:5) with the CRISPR system, and the preparation method thereof. The guide RNAs used in the invention target the capsid protein (CP) region of the wheat dwarf virus and inhibit the virus by causing DNA breaks in the relevant region with the Cas12(a) enzyme. Said antiviral solution is applied to the plant in spray form. By applying the RNPs contained in the antiviral solution of the invention to the leaves of the plant in spray form, no modification occurs in the genetics of the applied plant.

[0014] The aim of the invention is to neutralise the wheat dwarf virus. In the invention, the solution containing said RNP structure targets the capsid protein (CP) region in the genome of the wheat dwarf virus on the infected plant surface and DNA breaks are created in the region with the Cas12a enzyme. DNA breaks in the relevant region inhibit the replication of the virus and, accordingly, the virus itself.

[0015] Another aim of the invention is to neutralise wheat dwarf virus easily and at low cost. The antiviral solution of the invention can be easily applied to the plant by spraying it in spray form. In addition, although the solution comprises the CRISPR system, it is a low-cost solution because it does not cause any genetic changes and therefore does not require complex procedures.

[0016] Another aim of the invention is to neutralise the wheat dwarf virus without threatening living health. In the invention, the genome of the wheat dwarf virus is directly targeted, therefore no genetic changes occur in the plant, therefore consuming these plants does not cause any side effects or damage to living things.

[0017] Another aim of the invention is to provide a ribonucleic protein structure with high stability. The RNP structure in the antiviral solution of the invention is covered with graphene oxide, thus making said structure more stable against physical external factors.

[0018] Description of Drawings

[0019] Figure 1. The efficiencies of guide RNA-1 with the nucleotide sequence of SEQ ID NO:1 and guide RNA-2 with the nucleotide sequence of SEQ ID NO:2 isolated from different cities of Turkey in cleaving the virus DNA, compared to the control without Cas12a enzyme (A: TR_MW3875O5_I34, B: TR_0Q190468, C: TR_139 (does not have NCBI code), D: TR_OQ23O451_I41 , F: TR_MW3875O2_I54, G: TR_MW381791_I56, H: TR_OQ183229_I66, J: TR_0Q183230_l76, K: TR_177 (does not have NCBI code, 1 : uncut control and guide RNA-1 / guide RNA-2 (not containing Cas12a), 2: guide RNA-1 and Cas12a, 3: guide RNA-2 and Cas12a, 4: uncut control and guide RNA-1 / guide RNA- 2, 5: guide RNA-1 and Cas12a, 6: guide RNA-2 and Cas12a), x axis: density, y axis: the ratio of the distance traveled by the substance of interest to the distance simultaneously travelled by the mobile phase.

[0020] Figure 2. Activities to check that guide RNA-1 with the nucleotide sequence of SEQ ID NO:1 and guide RNA-2 with the nucleotide sequence of SEQ ID NO:2 in three different plasmid DNAs are specific for Wheat Dwarf Virus (A: non-specific control sample A, B: non-specific control sample B, C: non-specific control sample C, 1 : guide RNA-1 and Cas12a, 2: guide RNA-2 and Cas12a), x axis: density, y axis: the ratio of the distance traveled by the substance of interest to the distance simultaneously travelled by the mobile phase.

[0021] Detailed Description of the Invention

[0022] In the invention an antiviral solution containing the ribonucleic protein (RNP) structure that is packaged with graphene oxide, directly neutralises the wheat dwarf virus, which causes yellowing and dwarfism in wheat and / or barley, on the plant surface, and created from Cas12(a) and guide RNAs (Guide RNA-1 with the nucleotide sequence of SEQ ID NO:1 , Guide RNA-2 with the nucleotide sequence of SEQ ID NO:2, Guide RNA-3 with the nucleotide sequence of SEQ ID NO:3, Guide RNA-4 with the nucleotide sequence of SEQ ID NO:4 and guide RNA-5 with the nucleotide sequence of SEQ ID NO:5) with the CRISPR system, and the preparation method thereof, are described. The guide RNAs used in the invention target the capsid protein (CP) coding region of the wheat dwarf virus with the nucleotide sequence SEQ ID NO: 6, and inhibition of the virus is achieved by causing DNA breaks in the relevant region with the Cas12 enzyme. The application of said antiviral solution to the infected plant is by spraying it in spray form. By applying the RNPs contained in the antiviral solution of the invention in spray form to the leaves of the plant, no modification occurs in the genetics of the applied plant, and the genome of the wheat dwarf virus is directly targeted.

[0023] The antiviral solution that is the subject of the invention comprises the ribonucleoic protein (RNP) structure created from 0.00425 X TE (Tris-EDTA) buffer, 0.21 mg / ml PEG (polyethylene glycol), Cas12 and guide RNAs (Guide RNA-1 with the nucleotide sequence of SEQ ID NO:1 , Guide RNA-2 with the nucleotide sequence of SEQ ID NO:2, Guide RNA- 3 with the nucleotide sequence of SEQ ID NO:3, Guide RNA-4 with the nucleotide sequence of SEQ ID NO:4 and guide RNA-5 with the nucleotide sequence of SEQ ID NO:5) coated with 0.0085mg / ml graphene oxide and 20 ml ddF (deionized water).

[0024] As seen in Figure 1 , The test results of 10 Wheat Dwarf Virus DNAs (OQ183228_KRSH- I43, OQ183229_KRSH-I66, OQ230451_KRSH-I41 , OQ19O468_KRSH-I38,

[0025] OQ183230_KNY-I76, MW3875O5_KNY-I34, MW3875O2_AFY-I54, MW381791_ NVS- I56) isolated from wheat and barley collected from different cities in Turkey and the guide RNA with the nucleotide sequence of SEQ ID NO:1 and the guide RNA with the nucleotide sequence of SEQ ID NO:2 are given. Additionally, an uncut control experiment in which there is no Cas12a enzyme in the medium is also shown to check that each guide RNA does not give false results and whether the Cas12a enzyme works. In addition, in order to show that the guide RNAs designed in the invention are specific to wheat dwarf virus, guide RNA-1 with the nucleotide sequence of SEQ ID NO: 1 and guide RNA-2 with the nucleotide sequence of SEQ ID NO: 2 are tested in three different plasmid DNAs. As seen in Figure 2, the two guide RNAs designed in DNAs other than the wheat dwarf virus DNA do not cause a break in the DNA. Thus, it is proven by molecular analysis that guide RNAs are specific to wheat dwarf virus.

[0026] The preparation method of the antiviral solution that inhibits and neutralises the wheat dwarf virus in wheat and / or barley, which is the subject of the invention, comprises the process steps of; i. creating ribonucleic protein structure with guide RNAs (Guide RNA-1 with the nucleotide sequence of SEQ ID NO:1 , Guide RNA-2 with the nucleotide sequence of SEQ ID NO:2, Guide RNA-3 with the nucleotide sequence of SEQ ID NO:3, Guide RNA-4 with the nucleotide sequence of SEQ ID NO:4 and guide RNA-5 with the nucleotide sequence of SEQ ID NO:5) and Cas12(a) enzyme, ii. coating the created RNP structure with graphene oxide and creating the RNP structure coated with graphene oxide, and ill. obtaining an antiviral solution by putting RNP coated with graphene oxide into spray form. While preparing said solution, first the RNP structure, that is, guide RNAs and Cas12(a) enzyme, is created and for this purpose, 900 ng Cas12a and 90 ng guide RNA are added to the medium containing 18pl 1X Cas12a reaction buffer and incubated at 37 °C for 15 minutes. 10X Cas12a reaction buffer contains 500 mM NaCI, 100 mM Tris-HCI, 100 mM MgCI2, 1 mg / ml ultrapure bovine serum albumin (BSA) and is diluted 1X with ddH2O before use. At this stage, the Cas12(a) enzyme was preferred because it is a more effective endonuclease in single-stranded DNA viruses. Due to the possibility that there are and will be variants of wheat dwarf virus, bioinformatic analysis of wheat dwarf virus DNA sequences isolated from different countries in the world and different cities in Turkey in the NCBI database was performed. Five different guide RNAs (SEQ ID NO:1 , SEK ID NO:2, SEK ID NO:3, SEK ID NO:4, SEK ID NO:5) specific to common conserved regions in each isolated DNA sequence were designed to target the region encoding the capsid protein of the virus with the sequence of SEQ ID NO: 6 nucleotides. After the RNP structure is formed, said structure is coated with graphene oxide. For coating purposes, the graphene oxide surface is first immobilised with a heterofunctional PBA (pyrene butyric acid) binder consisting of a pyrene ring system by keeping it at room temperature for 2 hours. Immobilisation ensures that it can be used more than once, is more resistant to various physical and chemical effects, and can be used for a long time. The reason for using PBA is to fix the RNP structure to the graphene oxide surface. Any dysfunctional PBA molecules (here 1 -pyrenebutyric acid) are blocked with amino-polyethylene glycol 5- alcohol (PEG) at 37 °C for 10 minutes, and finally, the RNP structure in 18 pl 1X Cas12a reaction buffer is immobilised by keeping it at 37 °C for 10 minutes. A carboxylate group at the terminal end of the hydrocarbon arm of the PBA linker covalently binds to the RNP structure and anchors it to the surface of graphene. By means of this coating, RNP has been made more stable and the solution has been given the ability to heal the plant. The antiviral solution of the invention was prepared by combining RNP structure coated with 0.00425 X TE buffer, 0.21 mg / ml PEG, and 0.0085mg / ml graphene oxide into the final solution at a rate of 91 .48% by volume in ddF and putting it in spray form.

[0027] The antiviral solution of the invention forms a protective layer on the surfaces of wheat and / or barley plants. As soon as the virus reaches the plant surface, the guide RNAs in the solution bind to the virus genome by means of the Cas12(a) enzyme and inhibit the wheat dwarf virus by breaking down the virus genome. In this way, wheat dwarf virus is neutralised in the infected plant.

[0028] REFERENCES

[0029] [1] Wheat dwarf virus. AGES. (n.d.). Retrieved January 31 , 2023, from https: / / www.ages.at / en / plant / plant-health / pests-from-a-to-z / wheat-dwarf-virus

[0030] [2] Pfrieme, A.-K., Ruckwied, B., HabekuR, A., Will, T., Stahl, A., Pillen, K., & Ordon, F. (2022, February 9). Identification and validation of quantitative trait loci for wheat dwarf virus resistance in wheat (Triticum spp..). Frontiers. Retrieved January 31 , 2023, from https: / / www. frontiersin.org / articles / 10.3389 / fDls.2022.828639 / full#:~:text=SymDtom s%20of%20WDV%20infection%20in,Lindblad%20and%20Waern%2C%202002).

[0031] [3] Bassil, K. L., Vakil, C., Sanborn, M., Cole, D. C., Kaur, J. S., & Kerr, K. J. (2007, October). Cancer health effects of pesticides: Systematic review. Canadian family physician Medecin de famille canadien. Retrieved January 31 , 2023, from https: / / www.ncbi.nlm.nih.gov / pmc / articles / PMC2231435 /

[0032] [4] Zhang, Y., laffaldano, B., & Qi, Y. (2021 , February 10). CRISPR ribonucleoprotein- mediated genetic engineering in plants. Plant communications. Retrieved February 17, 2023, from https: / / www.ncbi.nlm.nih.gov / pmc / articles / PMC8060726 /

[0033] [5] A simple method for spray-on gene editing in Planta - Researchgate. (n.d.). Retrieved

[0034] February 17, 2023, from https: / / www.researchgate.net / publication / 336828475_A_simple_method_for_spray -on_gene_editing_in_planta

Claims

CLAIMS1 . An antiviral solution to neutralise wheat dwarf virus in wheat and / or barley, comprising the ribonucleoic protein (RNP) structure created from 0.00425 X TE (Tris-EDTA) buffer, 0.21 mg / ml PEG (polyethylene glycol), Cas12 and guide RNAs (Guide RNA-1 with the nucleotide sequence of SEQ ID NO:1 , Guide RNA-2 with the nucleotide sequence of SEQ ID NO:2, Guide RNA-3 with the nucleotide sequence of SEQ ID NO:3, Guide RNA-4 with the nucleotide sequence of SEQ ID NO:4 and guide RNA-5 with the nucleotide sequence of SEQ ID NO:5) coated with 0.0085mg / ml graphene oxide and 20ml ddH2O (deionized water).

2. An antiviral solution according to Claim 1 , wherein said guide RNA-1 with the nucleotide sequence of SEQ ID NO:1 , Guide RNA-2 with nucleotide sequence SEQ ID NO:2, Guide RNA-3 with nucleotide sequence SEQ ID NO: 3, Guide RNA-4 with nucleotide sequence SEQ ID NO: 4, and Guide RNA-5 with nucleotide sequence SEQ ID NO:5 target the region encoding the capsid protein (CP) of the wheat dwarf virus with the nucleotide sequence SEQ ID NO:6.

3. An antiviral solution according to Claim 2, wherein; its method of application is in spray form.

4. The preparation method of the antiviral solution that inhibits and neutralises the wheat dwarf virus in wheat and / or barley, comprising the process steps of; i. creating ribonucleic protein structure with guide RNAs (Guide RNA-1 with the nucleotide sequence of SEQ ID NO:1 , Guide RNA-2 with the nucleotide sequence of SEQ ID NO:2, Guide RNA-3 with the nucleotide sequence of SEQ ID NO:3, Guide RNA-4 with the nucleotide sequence of SEQ ID NO:4 and guide RNA-5 with the nucleotide sequence of SEQ ID NO:5) and Cas12(a) enzyme, ii. coating the created RNP structure with graphene oxide and creating the RNP structure coated with graphene oxide, and ill. obtaining an antiviral solution by putting RNP coated with graphene oxide into spray form.

5. A method according to claim 4, wherein the structure of the ribonucleic protein in the process step (i) is formed by adding Cas12(a) and the guide RNAs mentioned in the (i) process step to the medium containing Cas12(a) reaction buffer and incubating it at 37 °C for 15 minutes.

6. A method according to claim 4, wherein coating the RNP structure mentioned in the process step (ii) with graphene oxide is completed as a result of immobilising graphene with a heterofunctional PBA (pyrene butyric acid) linker and then blocking any dysfunctional PBA molecules with amino-polyethylene glycol 5-alcohol (PEG) at 37 °C for 10 min and finally immobilising the RNP structure in Cas12(a) reaction buffer by keeping it at 37 °C for 10 minutes.

7. A method according to claim 6, wherein said any dysfunctional PBA molecule is 1-Pyrenebutyric acid.

8. A method according to claim 4, wherein the antiviral solution mentioned in the process step (iii) is formed by combining the graphene oxide-coated RNP structure created in the process step (ii) into the final solution in ddF at a rate of 91.48% by volume.

9. Antiviral solution prepared by a method according to claim 4.

10. An antiviral solution according to claim 1 for inactivating wheat dwarf virus in wheat and / or barley.